Abstract 4368806: Vitamin E is Differentially Associated with Cardiometabolic Risk and Metabolic Syndrome in Brazilian and U.S. Hispanic/Latino Populations

M Marcela Costa (University of Sao Paulo, Sao Paulo, Brazil) J Josiemer Mattei (HARVARD CHAN SCHOOL PUBLIC HEALTH, Boston, Massachusetts, United States) L Lais Duarte Batista (University of Sao Paulo, Sao Paulo, Brazil) C Cristiane Hermes Sales (University of Sao Paulo, Sao Paulo, Brazil) F Flavia Mori Sarti (University of Sao Paulo, Sao Paulo, Brazil) M Marcelo Macedo Rogero (University of Sao Paulo, Sao Paulo, Brazil) R Regina Mara Fisberg (University of Sao Paulo, Sao Paulo, Brazil)

Abstract

Introduction: Vitamin E (α-tocopherol) is a lipid-soluble antioxidant with anti-inflammatory effects, studied for its role in managing metabolic syndrome (MetS). This is especially important for vulnerable groups such as Hispanics/Latinos, who have higher cardiometabolic risk and often insufficient vitamin E intake. Significant heterogeneity within these populations may impact health outcomes. This study investigates associations between vitamin E intake and nutritional status with cardiometabolic profiles and MetS among Brazilians and U.S. Hispanic/Latino individuals. Hypothesis: We hypothesize that the relationships between vitamin E (intake and plasma/serum levels) and cardiometabolic markers and MetS differ between these populations. Methods: This cross-sectional study used data from the 2015 Health Survey of São Paulo (ISA) and the 2017–2018 NHANES focusing on Hispanic/Latino participants. Dietary intake was measured by two 24-hour recalls. Plasma/serum vitamin E concentrations were normalized by blood lipids (vit E/lipid). Cardiometabolic profile included total cholesterol, HDL-c, LDL-c, non-HDL-c, triglycerides, glucose, blood pressure, BMI, and waist circumference. MetS was defined by International Diabetes Federation criteria. Associations were evaluated with generalized linear models (p < 0.05). Results: In ISA and NHANES, adults composed 66.8% and 83.3% of participants; females were 47.2% and 50.3%. Median vit E/lipid was 2.74 mg/g (ISA) and 3.84 mg/g (NHANES), with inadequacy rates of 99.99% and 96.89%. MetS prevalence was 35.8% (ISA) and 65.5% (NHANES). In ISA, vit E/lipid was inversely associated with total cholesterol, LDL-c, non-HDL-c, and triglycerides. In NHANES, vit E/lipid was inversely associated with BMI, waist circumference, triglycerides, and directly with HDL-c. Vitamin E intake inversely related to triglycerides in both groups. MetS was inversely associated with vit E/lipid and intake in NHANES, and with vit E/lipid in ISA. Conclusions: Vitamin E intake and plasma concentrations are associated with cardiometabolic outcomes, showing different patterns by population. ISA data showed stronger links with plasma levels, while NHANES emphasized intake associations. These findings highlight the need for tailored strategies addressing vitamin E status and cardiometabolic health in diverse populations.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (7)

M

Marcela Costa

University of Sao Paulo, Sao Paulo, Brazil

J

Josiemer Mattei

HARVARD CHAN SCHOOL PUBLIC HEALTH, Boston, Massachusetts, United States

L

Lais Duarte Batista

University of Sao Paulo, Sao Paulo, Brazil

C

Cristiane Hermes Sales

University of Sao Paulo, Sao Paulo, Brazil

F

Flavia Mori Sarti

University of Sao Paulo, Sao Paulo, Brazil

M

Marcelo Macedo Rogero

University of Sao Paulo, Sao Paulo, Brazil

R

Regina Mara Fisberg

University of Sao Paulo, Sao Paulo, Brazil